Similarly, individual TET2 mutations in TP53-mutant AML were subclonal with a variant allele frequency (VAF) of 0.02, but biallelic TET2 mutations or mutations plus deletions in TET2 resulted in much higher VAFs and clonal dominance (Figure 1C). The gene discussed is TET2; the disease is acute myeloid leukemia.